Atopic Dermatitis Patients

1

Review clinical trials related to Atopic Dermatitis Patients. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica

The goal of this observational registry is to characterize the clinical features, severity, treatments, and outcomes of patients with atopic dermatitis in Costa Rica receiving systemic and advanced therapies in routine clinical practice. The main questions it aims to answer are: What are the demographic and clinical characteristics of patients with moderate-to-severe atopic dermatitis treated in specialized dermatology centers in Costa Rica? What treatments are used in real-world practice and how do they impact disease severity and patient-reported outcomes over time? Participants with atopic dermatitis receiving systemic or advanced therapies as part of their usual medical care will be followed longitudinally, with collection of clinical severity scores, treatment patterns, and outcomes during routine visits.

Participants needed: 50
Trial details
Biological sex: AllType: ObservationalSponsor: Caja Costarricense de Seguro SocialUpdated: Apr 8, 2026Locations: 1Duration: 5 Years
Eligibility criteria

Clinical diagnosis of atopic dermatitis according to accepted diagnostic criteri... [+4]

Lack of sufficient clinical data for severity or treatment assessment